Obsessive Compulsive Disorder (OCD) BHV4157-303

(Biohaven Pharmaceuticals, Inc)

Are you struggling with Obsessive Compulsive Disorder? This study might be for you!

Clinical trial to investigate the efficacy of troriluzole as an adjunctive therapy when added to standard of care to evaluate safety and tolerability of the investigational medication in obsessive compulsive disorder.

Qualified participants include:

  • Must be 18-65 years of age
  • Meet diagnostic criteria for OCD, single episode or recurrent
  • Targeting patients who had inadequate response to SOC medication
  •  Must be on SSRI for an adequate duration and dose
  •  Double blind, placebo controlled trial

Those that qualify will:

  • Receive study drug and study-related care with a board-certified psychiatrist and other clinical staff at no cost.
  • Receive reimbursement for study participation and costs.

For more information, contact [email protected] or call us 860.545.7476

Join our Research Registry

If you are interested in participating in research at the Clinical Trials Unit follow the link below to sign up for our research registry. This will allow us to contact you for current and future research opportunities at the CTU. If you have any questions, please email
[email protected]
 or call 860.545.7476.

Click here to join